132 related articles for article (PubMed ID: 33838964)
21. Comparison between immunohistochemical expression of cyclin D1 and p21 and histological malignancy graduation of oral squamous cell carcinomas.
Neves Ada C; Mesquita RA; Novelli MD; Toddai E; De Sousa SO
Braz Dent J; 2004; 15(2):93-8. PubMed ID: 15776189
[TBL] [Abstract][Full Text] [Related]
22. [Expression of voltage-gated potassium channel Kv3.4 in oral squamous cell carcinoma].
Wang R; Cai B; Xiang J; Zhu X; Jiang Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2016 Mar; 51(3):137-42. PubMed ID: 26980650
[TBL] [Abstract][Full Text] [Related]
23. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
[TBL] [Abstract][Full Text] [Related]
24. The oncogenic role of androgen receptors in promoting the growth of oral squamous cell carcinoma cells.
Wu TF; Luo FJ; Chang YL; Huang CM; Chiu WJ; Weng CF; Hsu YK; Yuan TC
Oral Dis; 2015 Apr; 21(3):320-7. PubMed ID: 25040852
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological significance of tumor cyclin D1 expression in oral cancer.
Ramos-García P; González-Moles MÁ; González-Ruiz L; Ayén Á; Ruiz-Ávila I; Bravo M; Gil-Montoya JA
Arch Oral Biol; 2019 Mar; 99():177-182. PubMed ID: 30721793
[TBL] [Abstract][Full Text] [Related]
26. Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias.
Rousseau A; Lim MS; Lin Z; Jordan RC
Oral Oncol; 2001 Apr; 37(3):268-75. PubMed ID: 11287281
[TBL] [Abstract][Full Text] [Related]
27. Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal disease.
Zhong LP; Zhu DW; William WN; Liu Y; Ma J; Yang CZ; Yang X; Wang LZ; Li J; Myers JN; Lee JJ; Zhang CP; Zhang ZY
Mol Cancer Ther; 2013 Jun; 12(6):1112-21. PubMed ID: 23515614
[TBL] [Abstract][Full Text] [Related]
28. Different patterns of expression of cell cycle control and local invasion-related proteins in oral squamous cell carcinoma affecting young patients.
Miranda Galvis M; Santos-Silva AR; Freitas Jardim J; Paiva Fonseca F; Lopes MA; de Almeida OP; Lópes Pinto CA; Kaminagakura E; Sawazaki-Calone I; Speight PM; Kowalski LP
J Oral Pathol Med; 2018 Jan; 47(1):32-39. PubMed ID: 28626969
[TBL] [Abstract][Full Text] [Related]
29. Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins.
Miyashita H; Uchida T; Mori S; Echigo S; Motegi K
Oncol Rep; 2003; 10(4):1045-8. PubMed ID: 12792768
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in Asian populations: insights from a meta-analysis.
Zhao Y; Yu D; Li H; Nie P; Zhu Y; Liu S; Zhu M; Fang B
PLoS One; 2014; 9(3):e93210. PubMed ID: 24675814
[TBL] [Abstract][Full Text] [Related]
31. Significance of cytoplasmic cyclin D1 expression in oral oncogenesis.
Ramos-García P; Bravo M; González-Ruiz L; González-Moles MÁ
Oral Dis; 2018 Mar; 24(1-2):98-102. PubMed ID: 29480608
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle proteins and the development of oral squamous cell carcinoma.
Schoelch ML; Regezi JA; Dekker NP; Ng IO; McMillan A; Ziober BL; Le QT; Silverman S; Fu KK
Oral Oncol; 1999 May; 35(3):333-42. PubMed ID: 10621856
[TBL] [Abstract][Full Text] [Related]
33. Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma.
Huang SF; Cheng SD; Chuang WY; Chen IH; Liao CT; Wang HM; Hsieh LL
World J Surg Oncol; 2012 Feb; 10():40. PubMed ID: 22336657
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia.
Patel SB; Manjunatha BS; Shah V; Soni N; Sutariya R
J Korean Assoc Oral Maxillofac Surg; 2017 Oct; 43(5):324-330. PubMed ID: 29142867
[TBL] [Abstract][Full Text] [Related]
35. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance.
Carlos de Vicente J; Herrero-Zapatero A; Fresno MF; López-Arranz JS
Oral Oncol; 2002 Apr; 38(3):301-8. PubMed ID: 11978554
[TBL] [Abstract][Full Text] [Related]
36. Asymmetrical proliferative pattern loss linked to cyclin D1 overexpression in adjacent non-tumour epithelium in oral squamous cell carcinoma.
Ramos-García P; González-Moles MÁ; Ayén Á; González-Ruiz L; Ruiz-Ávila I; Lenouvel D; Gil-Montoya JA; Bravo M
Arch Oral Biol; 2019 Jan; 97():12-17. PubMed ID: 30321764
[TBL] [Abstract][Full Text] [Related]
37. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity.
Shintani S; Mihara M; Nakahara Y; Kiyota A; Ueyama Y; Matsumura T; Wong DT
Oral Oncol; 2002 Apr; 38(3):235-43. PubMed ID: 11978545
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression.
Lam KY; Ng IO; Yuen AP; Kwong DL; Wei W
J Oral Pathol Med; 2000 Apr; 29(4):167-72. PubMed ID: 10766394
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis.
Nitta T; Sugihara K; Tsuyama S; Murata F
Cancer; 2000 Jan; 88(2):245-54. PubMed ID: 10640953
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
